In CML cells, JAK2 is constitutively active and directly binds to the SH2 domain of BCR-ABL1, leading to uncontrolled STAT3/5 phosphorylation. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.